MNI BRIEF: BOJ Tweaks Economic Assessment, Notes Some Weakness

MNI BRIEF: RBA Holds, Drops Future Cash Rate Hike Language

BOJ MUST PAY ATTENTION TO ECONOMY, PRICE MOVES

MNI: PBOC Drains Net CNY5 Bln Via OMO Tues; Rates Unchanged

MNI: PBOC Sets Yuan Parity Higher At 7.0985 Tues; -4.47% Y/Y

CHINA PBOC INJECTS CNY5 BILLION VIA 7-DAY REVERSE REPOS TUES

UK Timeline of Key Events (All Times in GMT)

Eurozone Timeline of Key Events (Times GMT)

Indonesian Sovereign Debt Steady, BI Rate Decision Wednesday

MNI BRIEF: Poilievre Calls QE 'Scam' And Would Limit BOC Remit

MNI: Growth Drag From Net Zero Carbon Goal Can Be Offset-OECD

MNI BRIEF: Lawmakers Signal Tough Hearing For BOC's Macklem

© 1982-2023 MNI. All rights reserved.
Terms | Privacy
Log Out
Free Trial

EMA Confirms Rolling Review Of China's Sinovac COVID-19 Vaccine

EU

The European Medicines Agency (EMA) has confirmed this morning that it is launching a rolling review of China's Sinovac COVID-19 vaccine for potential use in the EU.

  • Link to statement: https://www.ema.europa.eu/en/news/ema-starts-rolli...
  • "EMA will evaluate data as they become available to decide if the benefits outweigh the risks. The rolling review will continue until enough evidence is available for a formal marketing authorisation application."
  • So far, the EU has not approved the use of any vaccine not developed in the bloc, the US, or the UK, with approval still pending for Russia's Sputnik V vaccine as well.
  • Some EU countries, notably Hungary, have already begun to use non-EMA approved vaccines, with Sputnik V and China's Sinopharm vaccine already in use in the country.
Homepagemarkets-real-timePolitical RiskPolitical Risk BulletBulletMarketsFixed Income BulletsForeign Exchange Bullets

To read the full story

Close

Why MNI

MNI is the leading provider

of intelligence and analysis on the Global Fixed Income, Foreign Exchange and Energy markets. We use an innovative combination of real-time analysis, deep fundamental research and journalism to provide unique and actionable insights for traders and investors. Our "All signal, no noise" approach drives an intelligence service that is succinct and timely, which is highly regarded by our time constrained client base.

Our Head Office is in London with offices in Chicago, Washington and Beijing, as well as an on the ground presence in other major financial centres across the world.